Published in Crit Care Med on November 01, 1999
Investigations into the polydeterminant nature of sepsis. Crit Care Med (1999) 0.75
Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group. Crit Care Med (1997) 4.86
A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med (1987) 3.89
Sepsis syndrome: a valid clinical entity. Methylprednisolone Severe Sepsis Study Group. Crit Care Med (1989) 3.41
Hypothermia in the sepsis syndrome and clinical outcome. The Methylprednisolone Severe Sepsis Study Group. Crit Care Med (1992) 2.99
Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: a randomized, open-label, placebo-controlled multicenter trial. Crit Care Med (1994) 2.66
Effect of advance directives on the management of elderly critically ill patients. Crit Care Med (1998) 1.43
Early methylprednisolone treatment for septic syndrome and the adult respiratory distress syndrome. Chest (1987) 1.43
Staphylococcus epidermidis sepsis in surgical patients. Arch Surg (1984) 1.08
Enterococcal bacteremia in surgical patients. Arch Surg (1985) 1.07
Fungal sepsis in surgical patients. Arch Surg (1983) 1.04
Enterobacter bacteremia in surgical patients. Surgery (1986) 1.03
Ketoconazole prevents Candida sepsis in critically ill surgical patients. Arch Surg (1987) 1.00
Interaction of prostaglandins, activated complement, and granulocytes in clinical sepsis and hypotension. Surgery (1986) 0.94
Head and neck cancer in a young age group: high incidence in black patients. Head Neck Surg (1983) 0.90
Alteration of postischemic renal pathology by prostaglandin infusion. J Surg Res (1980) 0.88
Thromboxane, prostacyclin, and the hemodynamic effects of graded bacteremic shock. Circ Shock (1985) 0.87
The incidence of metastases after multimodal therapy for cancer of the head and neck. Cancer (1984) 0.82
Effect of prostaglandin E1 and steroid combination in the treatment of hemorrhagic shock. Adv Shock Res (1978) 0.82
Hemodynamic effects of carbon dioxide pneumoperitoneum during mechanical ventilation and positive end-expiratory pressure. J Trauma (1993) 0.81
Adverse effects of hypothermia in postoperative patients. Am J Surg (1985) 0.81
Evaluation of enzyme-linked immunosorbent assays for quantitation of eicosanoid mediators of sepsis syndrome. Shock (1996) 0.80
Decompression after gastric surgery. Gastrostomy versus nasogastric tube. Am Surg (1989) 0.80
Comparison of the hemodynamic effects of gasless abdominal distention and CO2 pneumoperitoneum during incremental positive end-expiratory pressure. J Surg Res (1995) 0.79
Histologic and hemodynamic effects of prostacyclin and prostaglandin E1 following oleic acid infusion. Surgery (1982) 0.79
Differences in eicosanoid and cytokine production between injury/hemorrhage and bacteremic shock in the pig. Shock (1997) 0.78
The hemodynamic effects of prostaglandin E1 (PGE1) in acute hypoxic respiratory failure. Adv Shock Res (1980) 0.78
Leukocyte aggregation response to quantitative plasma levels of C3a and C5a. Arch Surg (1986) 0.77
Interactions between outcomes and tumor response to preoperative cisplatin-sensitized radiotherapy in advanced head and neck cancer. Southern New Jersey Head and Neck Cancer Treatment Group. Am J Surg (1997) 0.77
Ketoconazole: a thromboxane synthetase and 5-lipoxygenase inhibitor with antimetastatic activity in B16-F10 melanoma. J Surg Res (1988) 0.77
Preoperative simultaneously administered cis-platinum plus radiation therapy for advanced squamous cell carcinoma of the head and neck. Head Neck Surg (1986) 0.77
Prostaglandin and complement interaction in clinical acute respiratory failure. Arch Surg (1986) 0.77
Thromboxane and prostacyclin in clinical acute respiratory failure. J Surg Res (1985) 0.76
Preoperative chemotherapy-sensitized radiation therapy for cervical metastases in head and neck cancer. Arch Otolaryngol Head Neck Surg (2000) 0.76
Neonatal homicide following Roe v Wade. JAMA (1992) 0.75
Hyperbaric oxygen in systemic inflammation ... HBO is not just a movie channel anymore. Crit Care Med (1998) 0.75
Interaction of prostaglandins, activated complement, and granulocytes in clinical sepsis and hypotension. Surgery (1988) 0.75
Platelet activating factor mediates cardiopulmonary dysfunction during graded bacteremic shock. J Trauma (1996) 0.75
Increased tissue glucose: an unusual response to shock in the nutria. Curr Surg (1979) 0.75
Interaction of thromboxane A2 and tissue pathology during graded bacteremia. J Trauma (1987) 0.75
Efficacy of jejunogram after jejunostomy insertion. Am Surg (1999) 0.75
Effect of ischemic skin flap elevation on tissue and plasma thromboxane A2 and prostacyclin production: modification by thromboxane synthetase inhibition. Ann Plast Surg (1988) 0.75
Thromboxane interaction with cardiopulmonary dysfunction in graded bacterial sepsis. J Trauma (1984) 0.75
Prostacyclin is neither sufficient alone nor necessary to cause pulmonary dysfunction: results from infusions of prostacyclin and antiprostacyclin antibody in porcine septic shock. Crit Care Med (2001) 0.75
Pathophysiologic plasma levels of leukotriene C4 in relation to the hemodynamic dysfunction and mediator release of graded bacteremia. Shock (1997) 0.75
Permeability of the shocked cell to ATP-MgCl2. Surg Forum (1979) 0.75
The effect of radiofrequency hyperthermia on the Ca755 murine adenocarcinoma. Cancer (1980) 0.75
Pilot study of cytokines in emergency department patients with systemic inflammatory response syndrome. Acad Emerg Med (1997) 0.75
Microbial filtrates activate granulocytes without complement or prostaglandins. Circ Shock (1986) 0.75
Reconstruction of the anterior mandible: a preliminary report. Compendium (1988) 0.75
Positive pressure respirations and pneumatic antishock garment application--hemodynamic response. J Trauma (1985) 0.75
Prostacyclin and thromboxane A2 in septic shock: species differences. Circ Shock (1986) 0.75
The cardiovascular hemodynamics and leukotriene kinetics during prostacyclin and anti-prostacyclin antibody infusions in septic shock. Shock (2000) 0.75
Interleukin-1 mediates hemodynamic dysfunction and release of eicosanoids and tumor necrosis factor during graded bacteremia. Shock (1999) 0.75
Crush syndrome with death following pneumatic antishock garment application. J Trauma (1984) 0.75
Hemodynamic effect of prostacyclin (PGI2) in acute hypoxic respiratory failure. Surg Forum (1979) 0.75
The hemodynamic effect of profound hypercapnia on acute hypoxic respiratory failure. Circ Shock (1983) 0.75
The effect of hemorrhagic shock on plasma amino acids and tissue energy substrates in the primate. Am Surg (1979) 0.75
Nd:YAG laser scalpel compared with conventional techniques in head and neck cancer surgery. Lasers Surg Med (1994) 0.75
Thromboxane A2 Mediates Hemodynamic and Respiratory Dysfunction in Graded Bacteremia. Surgery (1989) 0.75
Thromboxane A2 mediates hemodynamic and respiratory dysfunction in graded bacteremia. Surgery (1986) 0.75
Quantitative analysis of organ tissue damage after septic shock. Am Surg (2007) 0.75
Laser-assisted laparoscopic lumbar diskectomy. N J Med (1994) 0.75
Standard T-tube cholangiogram: a safe method of cholangiography. Bacteremia is an unlikely event after T-tube cholangiography. R I Med J (1985) 0.75